Moderna: Q2 Earnings Snapshot
In this article:
CAMBRIDGE, Mass. (AP) — CAMBRIDGE, Mass. (AP) — Moderna Inc. (MRNA) on Thursday reported a loss of $1.28 billion in its second quarter.
On a per-share basis, the Cambridge, Massachusetts-based company said it had a loss of $3.33.
The results exceeded Wall Street expectations. The average estimate of 12 analysts surveyed by Zacks Investment Research was for a loss of $3.47 per share.
The biotechnology company posted revenue of $241 million in the period, also exceeding Street forecasts. Ten analysts surveyed by Zacks expected $124.9 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on MRNA at https://www.zacks.com/ap/MRNA